Juvenile Idiopathic Arthritis Uveitis Follow-up

Updated: Jan 06, 2016
  • Author: Manolette R Roque, MD, MBA, FPAO; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Further Outpatient Care

Patients with JIA-associated uveitis need to be seen by an ophthalmologist regularly, every 3 or 4 months (more often if with active uveitis). It is easy to miss flare-ups due to the white and quiet presentation of this type of uveitis. Moreover, children often do not complain of visual problems, precluding the possibility of early detection.

Children with JIA-associated uveitis on systemic medications require meticulous monitoring (CBC, LFTs, BUN, creatinine) for drug toxicity (bone marrow, liver, kidney), disease complications (eg, glaucoma, cataract, band keratopathy), disease exacerbations, or breakthrough inflammation.


Inpatient & Outpatient Medications

The mainstay of therapy of the ocular inflammation in these patients consists of topical corticosteroids and cycloplegics.



The cause of JIA-associated uveitis is unknown. Therefore, the prevention of the disease has not been established.

Evaluate children who are at risk for JIA-related ocular complications on a frequent regular basis and monitor closely for the development of ocular inflammation.